US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SDEV
$7.48
▲+0.00%
SPCX
$158.96
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SDEV
$7.48
▲+0.00%
SPCX
$158.96
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
CNS Pharmaceuticals, Inc. - Common Stock
(NQ:
CNSP
)
5.325
UNCHANGED
Delayed Quote
Updated: 3:58 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CNS Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures FDA Approval for Protocol Amendment to Ongoing Potentially Pivotal Berubicin Trial
June 23, 2022
Via
Investor Brand Network
44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
↗
June 23, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
Via
Benzinga
Symptoms of Brain Tumors To Watch For
June 15, 2022
Via
Investor Brand Network
CNS Pharmaceuticals: Q1 Earnings Insights
↗
May 16, 2022
CNS Pharmaceuticals (NASDAQ:CNSP) reported its Q1 earnings results on Monday, May 16, 2022 at 08:35 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Study Suggests Healthcare Workers Don’t Know Enough About Childhood Brain Tumors
June 22, 2022
Via
Investor Brand Network
Study Finds That Brain Tumors May Originate from Different Site
June 08, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 06, 2022
Via
Benzinga
Exposure to Wildfires Amplifies Cancer Risk, New Study Finds
June 01, 2022
Via
Investor Brand Network
Genomic Sequencing Offers Hope in Diagnosis, Treatment of Brain Tumors
May 24, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at H.C. Wainwright Global Investment Conference
May 24, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Among Most Powerful of Chemotherapy Drugs
May 23, 2022
Via
Investor Brand Network
Lantern Pharma to Host Glioblastoma Multiforme Webinar to Mark Brain Tumor Awareness Month
May 19, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Abstract to be Presented at American Society of Clinical Oncology 2022 Annual Meeting
May 18, 2022
Via
Investor Brand Network
Updated Guidelines Shed Light on Using Radiation Against Brain Metastases
May 16, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2022 Financial, Corporate Update
May 16, 2022
Via
Investor Brand Network
Researchers Develop Models to Better Understand Brain Cancer Metastasis
May 11, 2022
Via
Investor Brand Network
Investor Event Turns Spotlight on Novel Brain Cancer Drug Candidate Global Trial Under Way by CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)
May 11, 2022
Via
Investor Brand Network
Study Finds Strong Link Between Hormone Drug, Growth of Brain Tumors
May 06, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’
May 05, 2022
Via
Investor Brand Network
27 Stocks Moving in Wednesday's Pre-Market Session
↗
May 04, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares rose 38.5% to $1.87 in pre-market trading after gaining around 5% on Tuesday. Brickell Biotech, Inc. (NASDAQ: BBI) rose 29% to $0....
Via
Benzinga
Johns Hopkins Researchers Receive Millions for New Cancer Research Projects
May 03, 2022
Via
Investor Brand Network
Researchers May Have Found New Way to Slow Progression of Cancer
May 02, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from Ethics Committee and Competent Authority in Spain for Potentially Pivotal Study
April 28, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 27, 2022
Gainers Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 9.9% to $1.0 during Wednesday's after-market session. The company's market cap stands at $15.0 million.
Via
Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Focused On Advancing Research On GBM Treatments
↗
April 25, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Plants Could Unlock Future Cancer Therapies
April 25, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
↗
April 22, 2022
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million.
Via
Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Focused on Advancing Research on Treatments for GBM, Other Cancers
April 22, 2022
Via
Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
April 19, 2022
Good morning! It's time to start off another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
JTC Team Announces Continuation of its Virtual Investor Spotlight Series with NASDAQ: AEZS, NASDAQ: CNSP, and NASDAQ: AREC
April 13, 2022
- Live video webcast events on Thursday, April 14 at 10 AM ET, 11:30 AM ET and 1 PM ET - FRENCHTOWN, NJ / ACCESSWIRE / April 13, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and...
From
JTC Team, LLC
Via
AccessWire
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
